Fibrinolytic and antithrombotic action of bromelain may eliminate thrombosis in heart patients
- 30 November 1980
- journal article
- Published by Elsevier BV in Medical Hypotheses
- Vol. 6 (11), 1123-1133
- https://doi.org/10.1016/0306-9877(80)90134-6
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- The mechanism of the physiological action of bromelainMedical Hypotheses, 1980
- Bromelain, a thilprotease from pineapple stem, depletes high molecular weight kininogen by activation of Hageman factor (factor XII)Thrombosis Research, 1979
- THROMBOLYTIC THERAPYBritish Medical Bulletin, 1978
- Antithrombotic potential of dihomo-gamma-linolenic acid in man.BMJ, 1977
- An endoperoxide aggregator (LASS), formed in platelets in response to thrombotic stimuli-purification, identification and unique biological significanceProstaglandins, 1974
- Chemical Debridement of BurnsAnnals of Surgery, 1974
- THE FIBRINOLYTIC PATHWAY OF HUMAN PLASMAThe Journal of Experimental Medicine, 1972
- Effect of bromelain (ananase®) on human platelet aggregationCellular and Molecular Life Sciences, 1972
- A PREALBUMIN ACTIVATOR OF PREKALLIKREINThe Journal of Experimental Medicine, 1971
- The “fibrin to clot” clotting time after oral streptokinase or papainLife Sciences, 1965